1. Radiotracers for in situ infection imaging: Experimental considerations for in vitro microbial uptake of gallium-68-labeled siderophores.
- Author
-
Akter A, Cooper MS, Darwesh AMF, Hider RC, Blower PJ, Price NM, Lyons O, Schelenz S, Mehra V, and Abbate V
- Subjects
- Enterobactin metabolism, Escherichia coli metabolism, Humans, Deferoxamine pharmacology, Deferoxamine metabolism, Gallium Radioisotopes, Siderophores metabolism
- Abstract
In vitro screening of gallium-68(
68 Ga)-siderophores in pathogens relevant to infections is valuable for determining species specificity, their effect on cell viability, and potential clinical applications. As the recognition and internalization of siderophores relies on the presence of receptor- and/or siderophore-binding proteins, the level of uptake can vary between species. Here, we report in vitro uptake validation in Escherichia coli with its native siderophore, enterobactin (ENT) ([68 Ga]Ga-ENT), considering different experimental factors. Compared with other reporting methods of uptake, '% Added dose/109 CFU/mL (% AD/109 CFU/mL),' considering the total viable count, showed a better comparison among microbial species. Later, in vitro screening with [68 Ga]Ga-desferrioxamine B (DFO-B) showed high uptake by Staphylococcus aureus and S. epidermidis; moderate uptake by Pseudomonas aeruginosa; poor uptake by E. coli, Candida albicans, and Aspergillus fumigatus; and no uptake by Enterococcus faecalis and C. glabrata. Except for S. epidermidis, [68 Ga]Ga-DFO-B did not reduce the cell viability., Competing Interests: Declaration of competing interest There are no competing interests from any authors., (Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF